NXY-059: A hopeful sign in the treatment of stroke

Stroke

Volumn 37, Issue 10, 2006, Pages 2649-2650

  Hess, David C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Neuroprotectants

Indexed keywords

CLOMETHIAZOLE; DISUFENTON SODIUM; GELATINASE B; LANICEMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; REACTIVE OXYGEN METABOLITE;

BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CLINICAL TRIAL; DRUG SAFETY; HUMAN; HYPOKALEMIA; LENGTH OF STAY; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; POST HOC ANALYSIS; PRIORITY JOURNAL; SHORT SURVEY; STROKE;

ANIMALS; BENZENESULFONATES; CALLITHRIX; CEREBROVASCULAR ACCIDENT; CHLORMETHIAZOLE; CLINICAL TRIALS, PHASE III; DOUBLE-BLIND METHOD; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID ANTAGONISTS; FIBRINOLYTIC AGENTS; FREE RADICAL SCAVENGERS; HEMORRHAGE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; NEUROPROTECTIVE AGENTS; NITROGEN OXIDES; PYRIDINES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RODENTIA; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 33749017039     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000240511.22775.a7     Document Type: Short Survey

References (14)

1. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588-600.
2. Kidwell CS, Liebeskind DS, Starkman S, Saver JL. Trends in acute ischemic stroke trials through the 20th century. Stroke. 2001;32:1349-1359.
3. STAIR. Recommendations for standards regarding pre-clinical neuroprotective and restorative drug development. Stroke. 1999;30:2752-2758.
4. Kuroda S, Tsuchidate R, Smith ML, Maples KR, Siesjo BK. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1999;19:778-787.
5. Sydserff SG, Borelli AR, Green AR, Cross AJ. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol. 2002;135:103-112.
6. Marshall JW, Duffin KJ, Green AR, Ridley RM. NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke. 2001;32:190-198.
7. Marshall JW, Cummings RM, Bowes LJ, Ridley RM, Green AR. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. Stroke. 2003;34:2228-2233.
8. Marshall JW, Green AR, Ridley RM. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Res. 2003;972:119-126.
9. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke. 2005;36:1954-1959.
10. Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribo M, Quintana M, Alvarez-Sabin J. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation. 2003;107:598-603.
11. He C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett. 1996;106:185-191.
12. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1014-R1030.
13. Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke. 2004;35:2220-2225.
14. Lapchak PA, Song D, Wei J, Zivin JA. Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores. Exp Neurol. 2004;188:279-285.